17 May 2013 - Molecular diagnostic company Response Genetics Inc (NasdaqCM:RGDX) said on Thursday that it has signed an agreement to join all of Blue Shield of California's provider networks.

This represents Response Genetics' first Blue Cross Blue Shield-affiliated deal and will offer Blue Shield of California's membership access to Response Genetics' portfolio of predictive genetic testing.

Blue Shield of California, an independent member of the Blue Cross Blue Shield Association, is a not-for-profit health plan with approximately 3.0 million members and 5,000 employees. Response Genetics' specialisation focuses on the linkage between the genetic profile of an individual cancer patient's tumour and various drugs that may be used to fight that cancer.

The partnership will provide Blue Shield of California members' access to Response Genetics Inc's personalised medicine.